featured
Cabozantinib in Recurrent/Metastatic Endometrial Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Phase II Trial of Cabozantinib in Recurrent/Metastatic Endometrial Cancer: A Study of the Princess Margaret, Chicago and California Consortia (NCI9322/PHL86)
Clin. Cancer Res 2020 Jan 28;[EPub Ahead of Print], NC Dhani, HW Hirte, L Wang, JV Burnier, A Jain, MO Butler, S Welch, GF Fleming, J Hurteau, K Matsuo, D Matei, W Jimenez, C Johnston, M Cristea, K Tonkin, P Ghatage, S Lheureux, A Mehta, J Quintos, Q Tan, S Kamel-Reid, O Ludkovski, MS Tsao, JJ Wright, AM OzaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.